Metabolism and Target Organ Damage

Milestone Achieved: Metabolism and Target Organ Damage Publishes Over 100 Articles

We extend our heartfelt thanks to our Editor-in-Chief, Prof. Amedeo Lonardo, as well as to every author, reviewer, and Editorial Board member for their invaluable contributions.

Call for Papers: Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD

This Special Issue aims to explore the dual impact of these factors on liver health, specifically focusing on Metabolic Dysfunction and Alcohol-associated Liver Disease (MetALD).

Call for Papers: Metabolic Mysteries – The Role of Copper Dysregulation in Liver Disease

Guest Editors Prof. Ralf Weiskirchen and Prof. Wolfgang Stremmel have been named among the world’s top 2% of scientists for 2024!

A Special Interview with Prof. Matias A Avila, Newly Appointed Editorial Board Member of Metabolism and Target Organ Damage

Dr. Matias A Avila is a Professor of Biochemistry and Molecular Biology at the University of Navarra and Co-Director of the Solid Tumors Program at Cima.

Congratulations! Twenty-eight Editorial Board Members of Metabolism and Target Organ Damage Named among World’s Top 2% of Scientists for 2024!

This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Most Recent | Most Viewed | Most Downloaded

Research progress and future prospects of small-molecule glucagon-like peptide-1 receptor agonists (GLP-1RAs)

Yinfang Tu, Haoyong Yu

Open Access Perspective DOI: 10.20517/mtod.2024.99 28 Jan 2025

Views: Downloads:

Download PDF

Metrnl plays a crucial role in the regulation of glycolipid metabolism

Jia Zhang, ... Xiaoming Zhou

Open Access Review DOI: 10.20517/mtod.2024.79 24 Jan 2025

Views: Downloads:

Download PDF

Exploring the regulatory impact of insulin on type I collagen synthesis in hepatic stellate cells through α5β1 integrin

Ralf Weiskirchen

Open Access Commentary DOI: 10.20517/mtod.2024.133 20 Jan 2025

Views: Downloads:

Download PDF

Artificial intelligence in cardiac metabolism: the next frontier in cardiovascular health

An-Tian Chen

, ... Jian Zhang

Open Access Opinion DOI: 10.20517/mtod.2024.82 6 Jan 2025

Views: Downloads:

Download PDF

Metabolic dysfunction-associated steatotic liver disease throughout the liver transplant cycle: a comprehensive review

Brian J. Wentworth

Open Access Review DOI: 10.20517/mtod.2024.45 25 Dec 2024

Views: Downloads:

Download PDF

Most Cited Papers In Last Two Years

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Stefano Ballestri

, ... Amedeo Lonardo

Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023

Views: Downloads:

Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Christopher D. Byrne

, Giovanni Targher

Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024

Views: Downloads:

Download PDF

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Simonetta Lugari, ... Amedeo Lonardo

Open Access Review DOI: 10.20517/mtod.2022.38 30 Mar 2023

Views: Downloads:

Download PDF

Webinars

Ongoing Special Issues

Topic: Metabolic Dysregulation and Liver Cancer: Pioneering the Future of Liver Disease

Prof. Matias A Avila; Dr. Maite G Fernandez-Barrena

Submission Deadline: 15 Oct 2025

Published articles: 0

Topic: Advances in Immunometabolism: Bridging Fundamental Mechanisms and Therapeutic Innovations

Prof. Zhinan Yin; Prof. Qian Wang; Prof. Ziyu Meng

Submission Deadline: 30 Jun 2025

Published articles: 0

Editorial Board

Partners

Data

447

Authors

320

Reviewers

109

Articles

On Board Editors

2021

Published Since

For Authors

For Reviewers

Peer Review Guidelines

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Topics Collection

Topic: Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Topic: Sex Differences in Dysmetabolic Organ Damage and Senescence

Topic: Metabolic and Bariatric Surgery: Current Situation and Future Challenges

Latest Issue

All Issues

Volume 5, Issue 1 (in progress)

2024 Annual Report of Metabolism and Target Organ Damage

Acknowledgment to Reviewers of Metabolism and Target Organ Damage in 2024

Milestone Achieved: Metabolism and Target Organ Damage Publishes Over 100 Articles

We extend our heartfelt thanks to our Editor-in-Chief, Prof. Amedeo Lonardo, as well as to every author, reviewer, and Editorial Board member for their invaluable contributions.

Call for Papers: Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD

This Special Issue aims to explore the dual impact of these factors on liver health, specifically focusing on Metabolic Dysfunction and Alcohol-associated Liver Disease (MetALD).

Call for Papers: Metabolic Mysteries – The Role of Copper Dysregulation in Liver Disease

Guest Editors Prof. Ralf Weiskirchen and Prof. Wolfgang Stremmel have been named among the world’s top 2% of scientists for 2024!

A Special Interview with Prof. Matias A Avila, Newly Appointed Editorial Board Member of Metabolism and Target Organ Damage

Dr. Matias A Avila is a Professor of Biochemistry and Molecular Biology at the University of Navarra and Co-Director of the Solid Tumors Program at Cima.

Congratulations! Twenty-eight Editorial Board Members of Metabolism and Target Organ Damage Named among World’s Top 2% of Scientists for 2024!

This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Published articles: 0

Topic: Advances in Immunometabolism: Bridging Fundamental Mechanisms and Therapeutic Innovations

Prof. Zhinan Yin; Prof. Qian Wang; Prof. Ziyu Meng

Submission Deadline: 30 Jun 2025

Published articles: 0

News

2024 Annual Report of Metabolism and Target Organ Damage

Acknowledgment to Reviewers of Metabolism and Target Organ Damage in 2024

Data

447

Authors

320

Reviewers

109

Articles

On Board Editors

2021

Published Since

Metabolism and Target Organ Damage

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Articles

Research progress and future prospects of small-molecule glucagon-like peptide-1 receptor agonists (GLP-1RAs)

Metrnl plays a crucial role in the regulation of glycolipid metabolism

Exploring the regulatory impact of insulin on type I collagen synthesis in hepatic stellate cells through α5β1 integrin

Artificial intelligence in cardiac metabolism: the next frontier in cardiovascular health

Metabolic dysfunction-associated steatotic liver disease throughout the liver transplant cycle: a comprehensive review

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Topic: Metabolic Dysregulation and Liver Cancer: Pioneering the Future of Liver Disease

Topic: Advances in Immunometabolism: Bridging Fundamental Mechanisms and Therapeutic Innovations

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Topic: Metabolic Dysregulation and Liver Cancer: Pioneering the Future of Liver Disease

Topic: Advances in Immunometabolism: Bridging Fundamental Mechanisms and Therapeutic Innovations

2024 Annual Report of Metabolism and Target Organ Damage

Acknowledgment to Reviewers of Metabolism and Target Organ Damage in 2024

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico